Skip to search.
 BSE  0.00% NSE Down 0.62%
Streaming
Ticker Tape: On

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM

7.66 Up 0.10(1.32%) 1:30AM|After Hours : 7.60 Down 0.06 (0.78%) 3:39AM

Add to Portfolio
Prev Close:7.56
Open:7.60
Bid:N/A
Ask:8.50 x 1000
1y Target Est:13.22
Beta:3.67
Next Earnings Date: 5-Aug-13KERX Earnings announcement
Day's Range:7.47 - 7.75
52wk Range:1.68 - 9.98
Volume:1,840,366
Avg Vol (3m):2,342,100
Market Cap:625.96M
P/E (ttm):N/A
EPS (ttm):-0.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KERX at this time.

Comparison

Symbol% ChgMkt Cap
KERXUp 1.32%625.96M
PFZ.L 0.00%173.71B
GSK.LDown 0.59%81.19B
AZN.LUp 0.12%40.63B
JNJ.MXUp 1.46%3.13T
» More Competitors

Key Statistics

Forward P/E (1 yr):109.43
P/S (ttm):88.26
Ex-Dividend Date:N/A
» More Key Statistics

Analysts

Annual EPS Est (Dec-13) :-0.32
Quarterly EPS Est (Jun-13) :-0.10
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.73

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Company Profile | Industry
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback